Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 8/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | DCLRE1B | Q9H816 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | AGXT | P21549 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17058080 | 0.76 | ALDH1A1 (0.34) | IDO1DCLRE1BGPR84AGXT | |
| SCHEMBL7984357 | 0.76 | ERN1 (0.42) | RIPK1CES2CES1IDO1DCLRE1B | |
| SCHEMBL489929 | 0.75 | RIPK1 (0.41) | RIPK1CES2CES1IDO1GPR84 | |
| SCHEMBL10195688 | 0.75 | RIPK1 (0.49) | RIPK1CES2CES1GPR84 | |
| SCHEMBL29518822 | 0.75 | RIPK1 (0.44) | RIPK1CES2CES1GPR84DPP4 | |
| SCHEMBL6283166 | 0.75 | RIPK1 (0.41) | RIPK1CES2CES1IDO1GPR84 | |
| SCHEMBL17552647 | 0.75 | RIPK1 (0.41) | RIPK1CES2CES1IDO1GPR84 | |
| SCHEMBL147511 | 0.75 | RIPK1 (0.41) | RIPK1CES2CES1IDO1GPR84 | |
| SCHEMBL20560658 | 0.75 | RIPK1 (0.41) | RIPK1CES2CES1IDO1GPR84 | |
| SCHEMBL698821 | 0.75 | RIPK1 (0.44) | RIPK1CES2CES1GPR84DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963451-B2 | Fused ring pyrimidine compound and pest control agent containing the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | CBR3, HRH2, HRH4 | RIPK1 2092/4885CES2 4030/4885CES1 3844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.